Cited by 105Adrenal and Paraganglionic TumorsAdrenal Hormones and DisordersHormonal Regulation and Hypertension

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Diagnostic Value of Urinary Steroid Profiling in the Evaluation of Adrenal Tumors

Open access

Kerkhofs, T. M. A., Kerstens, M. N., Kema, I. P., Willems, T. P., Haak, H. R.·2015·Hormones and Cancer

DOI 10.1007/s12672-015-0224-3PMC PMC4486399

Open this paper in CoChat — free account Open PDF

Abstract

Radiological examination may unexpectedly reveal an adrenal mass. Current algorithms for differentiating between benign and malignant lesions mainly rely on size and densitometry on unenhanced CT, which have limited specificity. We examined the diagnostic value of urinary steroid profiling by gas chromatography/mass-spectrometry (GC/MS) in differentiating between benign and malignant adrenal tumors. A retrospective study in two referral centers for patients with adrenal disease was performed. All urinary steroid profiles ordered for evaluation of an adrenal tumor between January 2000 and November 2011 were examined. Patients were diagnosed with adrenal cortical carcinoma (ACC), adrenal cortical adenoma (ACA), or other adrenal mass. Results of hormonal measurements, imaging studies, pathology reports, and clinical outcome were retrieved from medical records. The diagnostic value of individual urinary steroid metabolites was determined by receiver operating characteristics analysis. Cut-off values were compared to reference values from an age and gender-standardized population of healthy controls. Eighteen steroid metabolites were excreted in significantly higher concentrations in patients with ACC (n = 27) compared to patients with ACA (n = 107) or other adrenal conditions (n = 18). Tetrahydro-11-deoxycortisol (THS) at a cut-off value of 2.35 μmol/24 h differentiated ACC from other adrenal disorders with 100% sensitivity and 99% specificity. Elevated urinary excretion of THS was associated with a very high sensitivity and specificity to differentiate between an ACC and a benign adrenal mass. Urinary steroid profiling might be a useful diagnostic test for the evaluation of patients with an adrenal incidentaloma.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s12672-015-0224-3

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Fig. 1 a–d. Median urinary excretion of 22 metabolites in patients with ACC, functioning adenoma, non-functioning adenoma, or other adrenal tumors organized per steroid class. A androsterone, E etiocholanolone, DHEA dehydroepiandrosterone, 11-KE 11-keto-etiocholanolone, 11-HA 11-hydroxy-androsterone, 11-HE 11-hydroxy-eticholanolone, THE tetrahydrocortisone, THF tetrahydrocortisol, allo-THF allo-tetrahydrocortisol, THA tetrahydro-11-dehydrocorticosterone, THB tetrahydrocorticosterone, allo-THB allo-tetrahydrocorticosterone, allo-P2 allo-pregnanediol, P2 pregnanediol, P3 pregnanetriol, Polone epi-pregnanolone, THS tetrahydro-11-deoxycortisol, PDL pregnanediolone, PTL pregnanetriolone. Whiskers indicate range, * indicates significant difference between ACC and other groupsCC BY · PubMed Central

Fig. 2 a–d. Receiver operating characteristic (ROC) curve for tetrahydro-11-deoxycortisol, pregnanediol, pregnanetriol, and etiocholanolone for the diagnosis of adrenocortical carcinomaCC BY · PubMed Central

Fig. 3 a–d. Relationship between cut-off values, reference values, and measured urinary excretion of tetrahydro-11-deoxycortisol, pregnanediol, pregnanetriol, and etiocholanolone in 27 ACC patientsCC BY · PubMed Central

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458 · cited 3×
“These reactions, catalyzed by CYP11B1 (11-deoxycortisol→cortisol) and CYP11B2 (11-deoxycorticosterone→aldosterone), take place on the inner mitochondrial membrane (IMM) and are stimulated by ACTH [22].”
BackgroundInfluential
The Incidentally Discovered Adrenal Mass
Young, W. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmcp065470 · Cited by 1,090
Management of the clinically inapparent adrenal mass ("incidentaloma")
Grumbach, M. M., Biller, B. M. K., Braunstein, G. D., Campbell, K. K., Carney, J. A., Godley, P. A., Harris, E. L., Lee, J. K. T., Oertel, Y. C., Posner, M. C., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-5-200303040-00013 · Cited by 945
Cost-effectiveness analysis.
Robinson, R. (1993) · BMJ · doi:10.1136/bmj.307.6907.793 · Cited by 819
Pathologic features of prognostic significance in adrenocortical carcinoma
Weiss, L. M., Medeiros, L. J., & Vickery, A. L. (1989) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198903000-00004 · Cited by 818 · cited 1×
“In patients with ACC, the Weiss score (a set of nine histopathological criteria with prognostic value in adrenocortical tumors) was extracted from the original pathology reports and disease progression was staged according to the European Network for Study of Adrenal Tumors (ENSAT) staging system [16, 17].”
Method
The clinically inapparent adrenal mass: update in diagnosis and management
Mansmann, G., Lau, J., Balk, E., Rothberg, M., Miyachi, Y., & Bornstein, S. R. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0031 · Cited by 781
Prevalence of adrenal incidentaloma in a contemporary computerized tomography series
Bovio, S., Cataldi, A., Reimondo, G., Sperone, P., Novello, S., Berruti, A., Borasio, P., Fava, C., Dogliotti, L., Scagliotti, G. V., et al. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03344099 · Cited by 712
Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: Proposal for a Revised TNM Classification
Fassnacht, M., Johanssen, S., Quinkler, M., Bucsky, P., Willenberg, H. S., Beuschlein, F., Terzolo, M., Mueller, H., Hahner, S., Allolio, B., et al. (2009) · Cancer · doi:10.1002/cncr.24030 · Cited by 695
Steroidogenic enzymes: Structure, function, and role in regulation of steroid hormone biosynthesis
Hanukoglu, I. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90307-5 · Cited by 577
AME Position Statement on adrenal incidentaloma
Terzolo, M., Stigliano, A., Chiodini, I., Loli, P., Furlani, L., Arnaldi, G., Reimondo, G., Pia, A., Toscano, V., Zini, M., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-1147 · Cited by 523

Show all 26 references

Sorted by citations

Management of adrenal incidentalomas: European society of endocrinology clinical practice guideline in collaboration with the European network for the study of adrenal tumors
Fassnacht, M., Arlt, W., Bancos, I., Dralle, H., Newell-Price, J., Sahdev, A., Tabarin, A., Terzolo, M., Tsagarakis, S., & Dekkers, O. M. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0467 · Cited by 1,566
European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors
Faßnacht, M., Dekkers, O. M., Else, T., Baudin, É., Berruti, A., de Krijger, R. R., Haak, H. R., Mihai, R., Assié, G., & Terzolo, M. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0608 · Cited by 976
Self-citation
European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors
Faßnacht, M., Tsagarakis, S., Terzolo, M., Tabarin, A., Sahdev, A., Newell-Price, J. D. C., Pelsma, I. C. M., Marina, L., Lorenz, K., Bancos, I., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad066 · Cited by 849
Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
Faßnacht, M., Assié, G., Baudin, É., Eisenhofer, G., de la Fouchardière, C., Haak, H. R., de Krijger, R. R., Porpiglia, F., Terzolo, M., & Berruti, A. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.08.2099 · Cited by 446
Self-citation
Adrenal incidentaloma
Sherlock, M., Scarsbrook, A., Abbas, A., Fraser, S., Limumpornpetch, P., Dineen, R., & Stewart, P. M. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa008 · Cited by 347
“In particular, the cosecretion of a distinct combination of glucocorticoid and androgen metabolites is emerging as a sensitive diagnostic tool for ACC (342,348,349).”
Background
Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study
Bancos, I., Taylor, A. E., Chortis, V., Sitch, A. J., Jenkinson, C., Davidge-Pitts, C. J., Lang, K., Tsagarakis, S., Macech, M., Riester, A., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30218-7 · Cited by 250
Self-citation
Approach to the Patient With Adrenal Incidentaloma
Bancos, I., & Prete, A. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab512 · Cited by 201
Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism
Storbeck, K.-H., Schiffer, L., Baranowski, E. S., Chortis, V., Prete, A., Barnard, L., Gilligan, L. C., Taylor, A. E., Idkowiak, J., Arlt, W., et al. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00262 · Cited by 141
Mild autonomous cortisol secretion: pathophysiology, comorbidities and management approaches
Prete, A., & Bancos, I. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-00984-y · Cited by 130
High-resolution, accurate-mass (HRAM) mass spectrometry urine steroid profiling in the diagnosis of adrenal disorders
Hines, J. M., Bancos, I., Bancos, C., Singh, R. D., Avula, A. V., Young, W. F., Grebe, S. K., & Singh, R. J. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2017.271106 · Cited by 111
A 13-steroid serum panel based on LC-MS/MS: use in detection of adrenocortical carcinoma
Taylor, D. R., Ghataore, L., Couchman, L., Vincent, R. P., Whitelaw, B., Lewis, D., Diaz-Cano, S., Galata, G., Schulte, K.-M., Aylwin, S., et al. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2017.277624 · Cited by 109
Urine steroid metabolomics as a novel tool for detection of recurrent adrenocortical carcinoma
Chortis, V., Bancos, I., Nijman, T., Gilligan, L. C., Taylor, A. E., Ronchi, C. L., O’Reilly, M. W., Schreiner, J., Asia, M., Riester, A., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz141 · Cited by 93
Toward a Standardized Strategy of Clinical Metabolomics for the Advancement of Precision Medicine
Long, N. P., Nghi, T. D., Kang, Y. P., Anh, N. H., Kim, H. M., Park, S. K., & Kwon, S. W. (2020) · Metabolites · doi:10.3390/metabo10020051 · Cited by 95
Plasma steroid metabolome profiling for the diagnosis of adrenocortical carcinoma
Schweitzer, S., Kunz, M., Kurlbaum, M., Vey, J., Kendl, S., Deutschbein, T., Hahner, S., Fassnacht, M., Dandekar, T., & Kroiss, M. (2019) · European Journal of Endocrinology · doi:10.1530/eje-18-0782 · Cited by 85
From a single steroid to the steroidome: Trends and analytical challenges
Olesti, E., Boccard, J., Visconti, G., González‐Ruiz, V., & Rudaz, S. L. (2020) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2020.105797 · Cited by 74
Different types of urinary steroid profiling obtained by high-performance liquid chromatography and gas chromatography-mass spectrometry in patients with adrenocortical carcinoma
Velikanova, L. I., Shafigullina, Z. R., Lisitsin, A. A., Vorokhobina, N. V., Grigoryan, K., Kukhianidze, E. A., Strelnikova, E. G., Krivokhizhina, N. S., Krasnov, L. M., Fedorov, E. A., et al. (2016) · Hormones and Cancer · doi:10.1007/s12672-016-0267-0 · Cited by 62
Future directions in the diagnosis and medical treatment of adrenocortical carcinoma
Creemers, S. G., Hofland, L. J., Korpershoek, E., Franssen, G. J. H., van Kemenade, F. J., de Herder, W. W., & Feelders, R. A. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0452 · Cited by 61
Plasma Steroid Profiling in Patients With Adrenal Incidentaloma
Berke, K., Constantinescu, G. A., Masjkur, J. R., Kimpel, O., Dischinger, U., Peitzsch, M., Kwapiszewska, A., Dobrowolski, P., Nölting, S., Reincke, M., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab751 · Cited by 52
Effects of Hydrocortisone on the Regulation of Blood Pressure: Results From a Randomized Controlled Trial
Buning, J. W., van Faassen, M. H. J. R., Brummelman, P., Dullaart, R. P. F., van den Berg, G., van der Klauw, M. M., Kerstens, M. N., Stegeman, C. A., Kobold, A. C. M., Kema, I. P., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2216 · Cited by 51
Self-citation
Non-targeted LC-MS based metabolomics analysis of the urinary steroidal profile
Palermo, A., Botrè, F., de la Torre, X., & Zamboni, N. (2017) · Analytica Chimica Acta · doi:10.1016/j.aca.2017.01.055 · Cited by 47
Steroid biomarkers in human adrenal disease
Rege, J., Turcu, A. F., Else, T., Auchus, R. J., & Rainey, W. E. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.01.018 · Cited by 47
Metabolomic Biomarkers in Urine of Cushing’s Syndrome Patients
Kotłowska, A., Puzyn, T., Sworczak, K., Stepnowski, P., & Szefer, P. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020294 · Cited by 45
The Role of Biomarkers in Adrenocortical Carcinoma: A Review of Current Evidence and Future Perspectives
Mizdrak, M., Kurir, T. T., & Božić, J. (2021) · Biomedicines · doi:10.3390/biomedicines9020174 · Cited by 44
Developing treatment for adrenocortical carcinoma
Kerkhofs, T. M. A., Ettaieb, M. H. T., Hermsen, I. G. C., & Haak, H. R. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0318 · Cited by 41
Self-citation
Diagnosis of a malignant adrenal mass: the role of urinary steroid metabolite profiling
Bancos, I., & Arlt, W. (2017) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000333 · Cited by 43
The Steroid Profile of Adrenal Incidentalomas: Subtyping Subjects With High Cardiovascular Risk
Dalmazi, G. D., Fanelli, F., Zavatta, G., Bitti, S. R., Mezzullo, M., Repaci, A., Pelusi, C., Gambineri, A., Altieri, P., Mosconi, C., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00365 · Cited by 45
A comprehensive urinary steroid analysis strategy using two-dimensional gas chromatography – time of flight mass spectrometry
Bileck, A., Verouti, S. N., Escher, G., Vogt, B., & Groessl, M. (2018) · The Analyst · doi:10.1039/c7an01990d · Cited by 34
Recent Updates on the Management of Adrenal Incidentalomas
Park, S. S., & Kim, J. H. (2023) · Endocrinology and Metabolism · doi:10.3803/enm.2023.1779 · Cited by 39
Urine steroid profile as a new promising tool for the evaluation of adrenal tumors. Literature review
Castro, M. A., Valderrábano, P., Escobar-Morreale, H. F., Hanzu, F. A., & Casals, G. (2020) · Endocrine · doi:10.1007/s12020-020-02544-6 · Cited by 34
How to Differentiate Benign from Malignant Adrenocortical Tumors?
Viëtor, C. L., Creemers, S. G., van Kemenade, F. J., van Ginhoven, T. M., Hofland, L. J., & Feelders, R. A. (2021) · Cancers · doi:10.3390/cancers13174383 · Cited by 33
Molecular Imaging in the Management of Adrenocortical Cancer
Wong, K. K., Miller, B. S., Viglianti, B. L., Dwamena, B. A., Gauger, P. G., Cook, G., Colletti, P. M., Rubello, D., & Gross, M. D. (2016) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001112 · Cited by 29
Serum steroid profiling by mass spectrometry in adrenocortical tumors: diagnostic implications
Fanelli, F., & Dalmazi, G. D. (2019) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000475 · Cited by 28
Determination of reference intervals for urinary steroid profiling using a newly validated GC-MS/MS method
de Jong, W. H. A., Buitenwerf, E., Pranger, A. T., Riphagen, I. J., Wolffenbuttel, B. H. R., Kerstens, M. N., & Kema, I. P. (2017) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2016-1072 · Cited by 29
Self-citation
Long‐term magnesium supplementation improves glucocorticoid metabolism: A post‐hoc analysis of an intervention trial
Schutten, J. C., Joris, P. J., Minović, I., Post, A., van Beek, A. P., de Borst, M. H., Mensink, R. P., & Bakker, S. J. L. (2020) · Clinical Endocrinology · doi:10.1111/cen.14350 · Cited by 26
Steroid metabolites for diagnosing and predicting clinicopathological features in cortisol-producing adrenocortical carcinoma
Suzuki, S., Minamidate, T., Shiga, A., Ruike, Y., Ishiwata, K., Naito, K., Ishida, A., Deguchi, H., Fujimoto, M., Koide, H., et al. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-00652-y · Cited by 26
Simplified urinary steroid profiling by LC-MS as diagnostic tool for malignancy in adrenocortical tumors
Vogg, N., Müller, T., Floren, A., Dandekar, T., Riester, A., Dischinger, U., Kurlbaum, M., Kroiß, M., & Faßnacht, M. (2023) · Clinica Chimica Acta · doi:10.1016/j.cca.2023.117301 · Cited by 21
Preliminary evidence of altered steroidogenesis in women with Alzheimer’s disease: Have the patients “OLDER” adrenal zona reticularis?
Vaňková, M., Hill, M., Velíková, M., Včelák, J., Vacínová, G., Dvořáková, K., Lukášová, P., Vejražková, D., Rusina, R., Holmerová, I., et al. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.12.011 · Cited by 21
Cardiometabolic profile and urinary metabolomic alterations in non‐functioning adrenal incidentalomas: A review
Castro, M. A. (2022) · Clinical Endocrinology · doi:10.1111/cen.14745 · Cited by 20
The evolution of methods for urinary steroid metabolomics in clinical investigations particularly in childhood
Honour, J. W., Conway, E., Hodkinson, R., & Lam, F. (2018) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2018.02.013 · Cited by 20
The Potential of Steroid Profiling by Mass Spectrometry in the Management of Adrenocortical Carcinoma
Rossi, C., Cicalini, I., Verrocchio, S., Dalmazi, G. D., Federici, L., & Bucci, I. (2020) · Biomedicines · doi:10.3390/biomedicines8090314 · Cited by 21
Steroid Sulfation in Adrenal Tumors
Mueller, J. W., Vogg, N., Lightning, T. A., Weigand, I., Ronchi, C. L., Foster, P., & Kroiß, M. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab182 · Cited by 19
Approach to the Patient with Subclinical Cushing’s Syndrome
Ivović, M., Marina, L., Šojat, A. S., Tančić‐Gajić, M., Arizanović, Z., Kendereški, A., & Vujović, S. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200813134328 · Cited by 18
Future Directions in Diagnosis, Prognosis and Disease Monitoring of Adrenocortical Carcinoma: Novel Non-Invasive Biomarkers
Cheng, Y., Kou, W., Zhu, D., Yu, X., & Zhu, Y. T. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.811293 · Cited by 18
Steroidomics for the Prevention, Assessment, and Management of Cancers: A Systematic Review and Functional Analysis
Anh, N. H., Long, N. P., Kim, S. J., Min, J. E., Yoon, S. J., Kim, H. M., Yang, E., Hwang, E. S., Park, J. H., Hong, S., et al. (2019) · Metabolites · doi:10.3390/metabo9100199 · Cited by 17
Incomplete Pattern of Steroidogenic Protein Expression in Functioning Adrenocortical Carcinomas
Pereira, S. S., Costa, M. M., Gómez-Sánchez, C. E., Monteiro, M. P., & Pignatelli, D. (2020) · Biomedicines · doi:10.3390/biomedicines8080256 · Cited by 17
Personalized Care of Patients with Adrenocortical Carcinoma: A Comprehensive Approach
Miller, B. S., & Else, T. (2017) · Endocrine Practice · doi:10.4158/ep161719.ra · Cited by 15
Characterisation of the urinary steroid profile of patients with nonfunctioning adrenal incidentalomas: A matched controlled cross‐sectional study
Castro, M. A., Casals, G., Hanzu, F. A., Corrales, E. P., Cano, A. M. G., Lanza, V. F., del Rey-Mejías, Á. L., Pinedo, M. M., Escobar-Morreale, H. F., & Valderrábano, P. (2022) · Clinical Endocrinology · doi:10.1111/cen.14811 · Cited by 15
Novel methods in adrenal research: a metabolomics approach
Papathomas, T. G., Sun, N., Chortis, V., Taylor, A. E., Arlt, W., Richter, S., Eisenhofer, G., Ruiz-Babot, G., Guasti, L., & Walch, A. K. (2019) · Histochemistry and Cell Biology · doi:10.1007/s00418-019-01772-w · Cited by 14
Urinary steroid profiling by gas chromatography mass spectrometry: Early features of malignancy in patients with adrenal incidentalomas
Ривгатовна, Ш. З., Великанова, Л. И., Ворохобина, Н. В., Борисович, Ш. С., Lisitsin, A. A., Валерьевна, М. Е., Buinova, M. O., Бессонова, Е. А., & Kirsanov, D. O. (2018) · Steroids · doi:10.1016/j.steroids.2018.04.006 · Cited by 14
Gas Chromatography–Mass Spectrometry Analysis of Urinary Steroid Metabolomics for Detection of Early Signs of Adrenal Neoplasm Malignancy in Patients with Cushing’s Syndrome
Великанова, Л. И., Ривгатовна, Ш. З., Ворохобина, Н. В., & Валерьевна, М. Е. (2019) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-019-04597-8 · Cited by 12
Steroid metabolomics: machine learning and multidimensional diagnostics for adrenal cortical tumors, hyperplasias, and related disorders
Eisenhofer, G., Durán, C., Chavakis, T., & Cannistraci, C. V. (2019) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2019.07.002 · Cited by 13
Targeted metabolic profiling of urinary steroids with a focus on analytical accuracy and sample stability
Vogg, N., Müller, T., Floren, A., Dandekar, T., Scherf‐Clavel, O., Faßnacht, M., Kroiß, M., & Kurlbaum, M. (2022) · Journal of Mass Spectrometry and Advances in the Clinical Lab · doi:10.1016/j.jmsacl.2022.07.006 · Cited by 12
Adrenal incidentaloma: differential diagnosis and management strategies
Morelli, V., & Palmieri, S. (2018) · Minerva Endocrinology · doi:10.23736/s0391-1977.18.02868-7 · Cited by 12
Characteristics of preoperative steroid profiles and glucose metabolism in patients with primary aldosteronism developing adrenal insufficiency after adrenalectomy
Wang, X., Heinrich, D. A., Kunz, S. L., Heger, N., Sturm, L., Uhl, O., Beuschlein, F., Reincke, M., & Bidlingmaier, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-90901-4 · Cited by 10
Diagnostic and prognostic assessments of adrenocortical carcinomas by pathological features, immunohistochemical markers and reticular histochemistry staining
Gan, W., Han, X., Gong, Y., Yang, Y., Wang, C., & Zhang, Z. (2024) · Diagnostic Pathology · doi:10.1186/s13000-024-01496-z · Cited by 9
Early Detection of Recurrence and Progress Using Serum Steroid Profiling by LC–MS/MS in Patients with Adrenocortical Carcinoma
Kimpel, O., Altieri, B., Dischinger, U., Fuß, C. T., Kurlbaum, M., & Faßnacht, M. (2023) · Metabolites · doi:10.3390/metabo14010020 · Cited by 10
Recommandations françaises du Comité de Cancérologie de l’AFU – Actualisation 2018–2020 : tumeur de la surrénale
Savoie, P.-H., Murez, T., Fléchon, A., Sèbe, P., Rocher, L., Camparo, P., Morel-Journel, N., Ferretti, L., & Méjean, A. (2018) · The French Journal of Urology · doi:10.1016/j.purol.2019.01.011 · Cited by 9
Is the 1mg-dexamethasone suppression test a precise marker of glucocorticoid excess and cardiometabolic risk in patients with adrenal incidentalomas?
Castro, M. A., Hanzu, F. A., Corrales, E. P., Cano, A. M. G., Pinedo, M. M., Escobar-Morreale, H. F., Valderrábano, P., & Casals, G. (2023) · Endocrine · doi:10.1007/s12020-023-03429-0 · Cited by 9
Influence of sex and functional status on the value of serum steroid profiling in discriminating adrenocortical carcinoma from adrenocortical adenoma
Weng, Y., Tang, J., Zhang, X., Lin, D., Guo, Y., Liang, Y., Wang, L., Zhou, J., Li, Y., Lin, T.-X., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1435102 · Cited by 8
An untargeted metabolomics approach to evaluate enzymatically deconjugated steroids and intact steroid conjugates in urine as diagnostic biomarkers for adrenal tumors
Vogg, N., North, E., Gessner, A., Fels, F., Heinrich, M. R., Kroiß, M., Kurlbaum, M., Faßnacht, M., & Fromm, M. F. (2025) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2024-1337 · Cited by 6
The interpretation of immunometric, chromatographic and mass spectrometric data for steroids in diagnosis of endocrine disorders
Honour, J. W. (2024) · Steroids · doi:10.1016/j.steroids.2024.109502 · Cited by 7
Proteome analysis of adrenal cortical tumors
Kim, H. M., Lee, Y. K., & Koo, J. S. (2016) · Expert Review of Proteomics · doi:10.1080/14789450.2016.1210008 · Cited by 6
Urinary steroid profiling in diagnostic evaluation of an unusual adrenal mass
Lenders, N. F., & Greenfield, J. R. (2019) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-19-0090 · Cited by 7
Recommandations françaises du Comité de cancérologie de l’AFU - actualisation 2020-2022 : bilan de malignité d’un incidentalome surrénalien
Savoie, P.-H., Murez, T., Fléchon, A., Rocher, L., Ferretti, L., Morel-Journel, N., Camparo, P., & Méjean, A. (2020) · The French Journal of Urology · doi:10.1016/s1166-7087(20)30756-9 · Cited by 6
Was It an Adrenocortical Adenoma or an Adrenocortical Carcinoma? Limitation of the Weiss Scoring System in Determining the Malignant Potential of Adrenocortical Tumor: Report on Two Cases
Wong, C.-L., Fok, C.-K., Chan, Y., Tam, V. H.-K., & Fung, L. M. (2022) · Case Reports in Endocrinology · doi:10.1155/2022/7395050 · Cited by 6
Development and Characterization of 3-Dimensional Cell Culture Models of Adrenocortical Carcinoma
Feely, S., Mullen, N., Donlon, P. T., Reidy, E., Challapalli, R. S., Hassany, M., Sorushanova, A., Martínez, E. R., Owens, P., Quinn, A. M., et al. (2024) · Endocrinology · doi:10.1210/endocr/bqae159 · Cited by 6
Steroid profiling in adrenal disease
Mu, D., Sun, D., Qian, X., Ma, X., Qiu, L., Cheng, X., & Yu, S. (2023) · Clinica Chimica Acta · doi:10.1016/j.cca.2023.117749 · Cited by 5
The role of steroid metabolome analysis for the diagnosis and follow-up of adrenocortical tumors
Chortis, V. (2018) · Minerva Endocrinology · doi:10.23736/s0391-1977.18.02869-9 · Cited by 5
5th International ACC Symposium: An Outlook to Current and Future Research on the Biology of Adrenocortical Carcinoma: Diagnostic and Therapeutic Applications
Lalli, E., & Sasano, H. (2015) · Hormones and Cancer · doi:10.1007/s12672-015-0240-3 · Cited by 4
Delineating Pediatric Adrenocortical Tumors by GC-MS Urinary Steroid Metabolome Analysis: Observations From the MET Study
Wudy, S. A., Pons‐Kühnemann, J., Kunstreich, M., Redlich, A., Hartmann, M. F., & Kuhlen, M. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf613 · Cited by 3
Steroid biomarkers and the diagnosis of adrenal cortical carcinoma
Bancos, I., & Arlt, W. (2019) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2019.08.013 · Cited by 3
Analysis of steroid profiles by mass spectrometry: A new tool for exploring adrenal tumors?
Cambos, S., Chanson, P., & Tabarin, A. (2020) · Annales d Endocrinologie · doi:10.1016/j.ando.2020.12.001 · Cited by 3
Pure Androgen-Secreting Radiologically Suspicious Adrenal Mass: Benign or Malignant?
Gopinath, C., Shekar, S., Acharya, M. M., Pattan, V., & Sundaresh, V. (2022) · Cureus · doi:10.7759/cureus.26234 · Cited by 3
Study of urine steroid profiles by gas chromatography-mass spectrometry in patients with adrenocortical cancer in the course of treatment
Великанова, Л. И., Ворохобина, Н. В., Ривгатовна, Ш. З., Bokhian, V., Stilidi, I. S., Kalugina, V. V., Валерьевна, М. Е., Геннадьевна, С. Е., & Кушлинский, Н. Е. (2021) · Almanac of Clinical Medicine · doi:10.18786/2072-0505-2021-49-041 · Cited by 3
Adrenocortical carcinoma
Ettaieb, M. H. T. (2020) · Research Publications (Maastricht University) · doi:10.26481/dis.20201218me · Cited by 4
A quantitative, broad-panel LC-MS/MS method for the analysis of intact steroid conjugates: A novel approach to steroid profiling for biomarker research in corticoid-dependent diseases
North, E., Gessner, A., Kurlbaum, M., Faßnacht, M., Kroiß, M., Fromm, M. F., & Bartels, N. (2025) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2025.117258 · Cited by 2
Serum steroid profiling by LC-MS/MS in distinguishing adrenocortical carcinoma from other indeterminate adrenal masses
Rao, A. C., Phadte, A., Ban, A. A., Memon, S. S., Karlekar, M. P., Lila, A. R., Sarathi, V., Kansal, N., Barnabas, R., Badhe, P., et al. (2026) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2026.106937 · Cited by 4
The relationship between urine steroid metabolome and the course of adrenocortical cancer
Великанова, Л. И., Ворохобина, Н. В., Ривгатовна, Ш. З., Kalugina, V. V., Валерьевна, М. Е., Геннадьевна, С. Е., Buinova, M. O., Lisitsyn, A. A., & Кушлинский, Н. Е. (2023) · Almanac of Clinical Medicine · doi:10.18786/2072-0505-2023-51-018 · Cited by 2
Adrenocortical Carcinoma
Creemers, S. G., Hofland, L. J., & Feelders, R. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-44136-8_12 · Cited by 2
Molecular genetic aspects of adrenocortical cancer
Yashina, D. P., & Afanasyeva, Z. A. (2023) · Advances in molecular oncology · doi:10.17650/2313-805x-2023-10-2-42-57 · Cited by 1
A mellékvesekéreg-carcinoma diagnosztikája
Tõke, J., & Tóth, M. (2024) · Orvosi Hetilap · doi:10.1556/650.2024.32958 · Cited by 1
Clinical Application of Steroid Profiles and Their Interpretation in Adrenal Disorders
Ramasamy, I. (2026) · Diagnostics · doi:10.3390/diagnostics16030381 · Cited by 2
Modern possibilities of the urine steroid profile testing applying for the adrenocortical cancer diagnosis
Shcherbakov, I. E., Chernikov, R. A., Федорович, Р. В., Ea, F., Fedotov, U. N., Саблин, И. В., Чинчук, И. К., Sleptcov, I. V., Krasnov, L. M., Rebrova, D. V., et al. (2020) · Endocrine Surgery · doi:10.14341/serg12307 · Cited by 1
Prognostic markers of recurrence in adrenocortical carcinoma patients after surgery
Kalugina, V. V., Ворохобина, Н. В., Великанова, Л. И., Ривгатовна, Ш. З., Валерьевна, М. Е., Геннадьевна, С. Е., Bokhyan, V. Y., Альбертович, Б. Т., & Кушлинский, Н. Е. (2023) · HERALD of North-Western State Medical University named after I I Mechnikov · doi:10.17816/mechnikov233493 · Cited by 1
Advances in our understanding of the prognosis of adrenal incidentaloma
Mackay, I., & Aspinall, S. R. (2016) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2016.1233055 · Cited by 1
Steroid-Producing Tumours
Rumsby, G. (2018) · Springer eBooks · doi:10.1007/978-3-319-96364-8_15 · Cited by 1
Adrenocortical carcinoma : a study on epidemiology diagnostics and treatment of a rare endocrine malignancy
Kerkhofs, T. M. A. (2015) · doi:10.26481/dis.20151112tk · Cited by 1
Self-citation
RETRACTED: Recommandations françaises du Comité de Cancérologie de l’AFU — Actualisation 2018—2020 : tumeur de la surrénale
Savoie, P.-H., Murez, T., Fléchon, A., Sèbe, P., Rocher, L., Camparo, P., Morel-Journel, N., Ferretti, L., & Méjean, A. (2018) · The French Journal of Urology · doi:10.1016/j.purol.2018.08.015
Retracted
THE COMBINATION OF CLASSICAL TESTS AND METHODS OF CHROMATOGRAPHY FOR LABORATORY DIAGNOSTICS OF CUSHING’S SYNDROME OF DIFFERENT GENESIS
Ривгатовна, Ш. З., Великанова, Л. И., Ворохобина, Н. В., Валерьевна, М. Е., Геннадьевна, С. Е., & Pal’cman, Z. V. (2020) · Russian Clinical Laboratory Diagnostics · doi:10.18821/0869-2084-2020-65-7-418-423
La metabolomica nella diagnosi delle patologie da ipersecrezione e dei tumori corticali surrenalici
Dalmazi, G. D. (2021) · L Endocrinologo · doi:10.1007/s40619-021-00957-7
Nebennierentumoren mit Androgen-/Östrogen-Überproduktion
Ladurner, R. (2021) · Springer Reference Medizin · doi:10.1007/978-3-662-61724-3_33-1
Specific characteristics of metabolomics as assessed by gas chromatography-mass spectrometry in patients with adrenocortical cancer and with adrenal incidentalomas in congenital adrenal hyperplasia
Ривгатовна, Ш. З., Великанова, Л. И., Ворохобина, Н. В., Валерьевна, М. Е., Геннадьевна, С. Е., Bokhian, V., Альбертович, Б. Т., & Stilidi, I. S. (2022) · Almanac of Clinical Medicine · doi:10.18786/2072-0505-2022-50-007
Применение газовой хромато-масс-спектрометрии для диагностики заболеваний надпочечников (обзор литературы)
Валерьевна, М. Е., Геннадьевна, С. Е., & Зыбина, Н. Н. (2019) · ANALYTICS Russia · doi:10.22184/2227-572x.2019.9.6.478.484
The Demonstration of Tumor Heterogeneity using 2DE Proteomic Approach
Kanlı, A., Şimşek, T., Kasap, M., Akpınar, G., & Cantürk, Z. (2022) · Sakarya Medical Journal · doi:10.31832/smj.1066524
Health aspects of magnesium status and supplementation
Schutten, J. C. (2022) · doi:10.33612/diss.252055798
Nebennierentumoren mit Androgen-/Östrogen-Überproduktion
Ladurner, R. (2022) · Springer Reference Medizin · doi:10.1007/978-3-662-63317-5_33
Mineralocorticoid excess
Honour, J. W. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-818124-9.00005-x
Steroid Profiling in the Differential Diagnosis of Cushing's Syndrome and Diagnosis of MACS
Nankova, A., Kamenova, T., Vasilev, V., Elenkova, A., Svinarov, D. A., Кirilov, G., & Zaharieva, S. (2024) · Acta Medica Bulgarica · doi:10.2478/amb-2024-0012
A multi-stage metabolic pattern of adrenocortical adenomas offers diagnostic potential of uric acid, isocitric acid, and proline
Yang, Q., Sun, Q., Zhang, Y., Gong, R., Wang, M., Li, J., Lai, M., & Lai, C. (2025) · Metabolomics · doi:10.1007/s11306-025-02284-6
Thrombopoiesis and Androgen Biosynthesis in Patients with Adrenal Cortex Tumors
Kalugina, V. V., Ворохобина, Н. В., Великанова, Л. И., Ривгатовна, Ш. З., Валерьевна, М. Е., & Lisitsyn, A. A. (2025) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s1990750824601012

Authors: Kerkhofs, T. M. A., Kerstens, M. N., Kema, I. P., Willems, T. P., & Haak, H. R.
Affiliations: Máxima Medisch Centrum (NL)
University Medical Center Groningen (NL)
Maastricht University Medical Centre (NL)
Corresponding author: Kerkhofs, T. M. A.
ORCID: Kerkhofs, T. M. A.
Kema, I. P.
Willems, T. P.
Haak, H. R.
Venue: Hormones and Cancer
Publisher: Springer Science and Business Media LLC
Published: 2015-05-19
Volume: 6
Issue: 4
Pages: 168-175
ISSN: 1868-8497 (ISSN-L)
1868-8500
DOI: 10.1007/s12672-015-0224-3
PMC: PMC4486399
OpenAlex: W1829257219
Cited by: 102
References: 26
Citations by year: 2026: 3 · 2025: 5 · 2024: 7 · 2023: 10 · 2022: 10 · 2021: 9 · 2020: 16 · 2019: 12 · 2018: 10 · 2017: 7 · 2016: 7 · 2015: 6
FWCI: 10.08
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by
creativecommons.org/licenses/by/4.0 (unspecified)
Locations: Hormones and Cancer (publishedVersion, cc-by)
Europe PMC (PubMed Central) (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
Research Publications (Maastricht University) (publishedVersion, cc-by)
University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
Research Publications (Maastricht University) (submittedVersion, other-oa)
Topics: Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
Keywords: urinary steroid profiling, adrenal tumors, adrenocortical carcinoma, adrenal adenoma, adrenal incidentaloma, benign versus malignant differentiation, diagnostic accuracy, gas chromatography-mass spectrometry
MeSH terms: Adrenal Cortex Neoplasms, Adult, Aged, Carcinoma, Cortodoxone, Female, Humans, Male, Middle Aged, Prognosis, Steroids, Cohort Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Diagnostic Value of Urinary Steroid Profiling in the Evaluation of Adrenal Tumors

Abstract

Overview

Integrity signals

Figures

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks